Skip to main content
Log in

Dynapenic Abdominal Obesity and Risk of Heart Disease among Middle-Aged and Older Adults: A Prospective Cohort Study

  • Original Research
  • Published:
The journal of nutrition, health & aging
  • 2 Altmetric

Abstract

Objectives

The vicious cycle of dynapenia and abdominal obesity may have synergistic detrimental impacts on health. We aim to investigate the prospective association between dynapenic abdominal obesity and the risk of heart disease among middle-aged and older adults.

Design

A prospective cohort study.

Setting

English Longitudinal Study of Ageing, 2002–2019.

Participants

A total of 4734 participants aged 50 years and older were included.

Measurements

Individuals were divided into non-dynapenia/non-abdominal obesity (ND/NAO), non-dynapenia/abdominal obesity (ND/AO), dynapenia/non-abdominal obesity (D/NAO), and dynapenia/abdominal obesity (D/AO) according to grip strength and waist circumference at baseline. The Cox proportional hazards models were used to obtain the hazard ratios (HRs) of incident heart disease associated with dynapenia and abdominal obesity after adjusting for potential confounding factors.

Results

During a median follow-up of 9.5 years, 1040 cases of heart disease were recorded. Compared with ND/NAO group, the multivariable HRs were 1.05 (0.92, 1.21) for ND/AO group, 1.31 (0.96, 1.81) for D/NAO group, and 1.39 (1.03, 1.88) for D/AO group. The significant association of D/AO with incident heart disease was detected in women but not in men [HR = 1.55 (1.07, 2.24) and 1.06 (0.60, 1.88), respectively]. Among middle-aged adults, significant associations of D/NAO and D/AO with incident heart disease were observed [HR = 2.46 (1.42, 4.29) and 1.74 (1.02, 2.97), respectively].

Conclusion

Both D/NAO and D/AO might increase the risk of developing heart disease, highlighting the importance of dynapenia and obesity early screening for heart disease prevention.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2

Similar content being viewed by others

Availability of data and materials: The data involved in this study are freely available from the UK Data Service (https://www.elsa-project.ac.uk/).

Abbreviations

ELSA:

English Longitudinal Study of Ageing

ND/NAO:

nondynapenic/nonabdominal obesity

D/NAO:

dynapenic/nonabdominal obesity

ND/AO:

nondynapenic/abdominal obesity

D/AO:

dynapenic/abdominal obesity.

References

  1. Manini TM, Clark BC. Dynapenia and aging: an update. J Gerontol A Biol Sci Med Sci. Jan 2012;67(1):28–40. doi:https://doi.org/10.1093/gerona/glr010

    Article  PubMed  Google Scholar 

  2. Rodriguez-Garcia WD, Garcia-Castaneda L, Vaquero-Barbosa N, et al. Prevalence of dynapenia and presarcopenia related to aging in adult community-dwelling Mexicans using two different cut-off points. Eur Geriatr Med. Apr 2018;9(2):219–225. doi:https://doi.org/10.1007/s41999-018-0032-8

    Article  PubMed  Google Scholar 

  3. Araujo FC, Silva KSD, Ohara DG, Matos AP, Pinto A, Pegorari MS. Prevalence of and risk factors for dynapenic abdominal obesity in community-dwelling older adults: a cross-sectional study. Cien Saude Colet. Feb 2022;27(2):761–769. doi:https://doi.org/10.1590/1413-81232022272.01122021

    Article  PubMed  Google Scholar 

  4. Kuk JL, Saunders TJ, Davidson LE, Ross R. Age-related changes in total and regional fat distribution. Ageing Res Rev. Oct 2009;8(4):339–48. doi:https://doi.org/10.1016/j.arr.2009.06.001

    Article  PubMed  Google Scholar 

  5. Hong SH, Choi KM. Sarcopenic Obesity, Insulin Resistance, and Their Implications in Cardiovascular and Metabolic Consequences. Int J Mol Sci. Jan 13 2020;21(2) doi:https://doi.org/10.3390/ijms21020494

    Google Scholar 

  6. Hu L, Huang X, You C, et al. Prevalence of overweight, obesity, abdominal obesity and obesity-related risk factors in southern China. PLoS One. 2017;12(9):e0183934. doi:https://doi.org/10.1371/journal.pone.0183934

    Article  PubMed  PubMed Central  Google Scholar 

  7. Li CW, Yu K, Shyh-Chang N, et al. Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review. J Cachexia Sarcopenia Muscle. Feb 2 2022;doi:https://doi.org/10.1002/jcsm.12901

  8. Oba K, Tamura Y, Ishikawa J, et al. Dynapenic abdominal obesity is associated with mild cognitive impairment in patients with cardiometabolic disease: a cross-sectional study. BMC Geriatr. Mar 28 2022;22(1):255. doi:https://doi.org/10.1186/s12877-022-02948-1

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Alexandre TDS, Scholes S, Ferreira Santos JL, Duarte YAO, de Oliveira C. The combination of dynapenia and abdominal obesity as a risk factor for worse trajectories of IADL disability among older adults. Clin Nutr. Dec 2018;37(6 Pt A):2045–2053. doi:https://doi.org/10.1016/j.clnu.2017.09.018

    Article  PubMed  Google Scholar 

  10. Maximo RO, de Oliveira DC, Ramirez PC, et al. Combination of dynapenia and abdominal obesity affects long-term physical performance trajectories in older adults: Sex differences. Am J Clin Nutr. Jan 31 2022;doi:https://doi.org/10.1093/ajcn/nqac023

  11. de Oliveira Maximo R, de Oliveira DC, Ramirez PC, et al. Dynapenia, abdominal obesity or both: which accelerates the gait speed decline most? Age Ageing. Sep 11 2021;50(5):1616–1625. doi:https://doi.org/10.1093/ageing/afab093

    Article  PubMed  PubMed Central  Google Scholar 

  12. Zhang L, Liu S, Wang W, et al. Dynapenic abdominal obesity and the effect on long-term gait speed and falls in older adults. Clin Nutr. Jan 2022;41(1):91–96. doi:https://doi.org/10.1016/j.clnu.2021.11.011

    Article  PubMed  Google Scholar 

  13. Dowling L, Cuthbertson DJ, Walsh JS. Reduced muscle strength (dynapenia) in women with obesity confers a greater risk of falls and fractures in the UK Biobank. Obesity (Silver Spring). Feb 2023;31(2):496–505. doi:https://doi.org/10.1002/oby.23609

    Article  CAS  PubMed  Google Scholar 

  14. Rossi AP, Bianchi L, Volpato S, et al. Dynapenic Abdominal Obesity as a Predictor of Worsening Disability, Hospitalization, and Mortality in Older Adults: Results From the InCHIANTI Study. J Gerontol A Biol Sci Med Sci. Aug 1 2017;72(8):1098–1104. doi:https://doi.org/10.1093/gerona/glw203

    Article  PubMed  PubMed Central  Google Scholar 

  15. Rossi AP, Fantin F, Caliari C, et al. Dynapenic abdominal obesity as predictor of mortality and disability worsening in older adults: A 10-year prospective study. Clin Nutr. Feb 2016;35(1):199–204. doi:https://doi.org/10.1016/j.clnu.2015.02.005

    Article  PubMed  Google Scholar 

  16. Senechal M, Dionne IJ, Brochu M. Dynapenic abdominal obesity and metabolic risk factors in adults 50 years of age and older. J Aging Health. Aug 2012;24(5):812–26. doi:https://doi.org/10.1177/0898264312440324

    Article  PubMed  Google Scholar 

  17. Kowall B. Lower body muscle strength, dynapenic obesity and risk of type 2 diabetes -longitudinal results on the chair-stand test from the Survey of Health, Ageing and Retirement in Europe (SHARE). BMC Geriatr. Dec 1 2022;22(1):924. doi:https://doi.org/10.1186/s12877-022-03647-7

    Article  PubMed  PubMed Central  Google Scholar 

  18. Ramirez PC, de Oliveira DC, de Oliveira Maximo R, et al. Is dynapenic abdominal obesity a risk factor for cardiovascular mortality? A competing risk analysis. Age Ageing. Jan 8 2023;52(1)doi:https://doi.org/10.1093/ageing/afac301

    Google Scholar 

  19. Celis-Morales CA, Welsh P, Lyall DM, et al. Associations of grip strength with cardiovascular, respiratory, and cancer outcomes and all cause mortality: prospective cohort study of half a million UK Biobank participants. BMJ. May 8 2018;361:k1651. doi:https://doi.org/10.1136/bmj.k1651

    Article  PubMed  PubMed Central  Google Scholar 

  20. Xue R, Li Q, Geng Y, Wang H, Wang F, Zhang S. Abdominal obesity and risk of CVD: a dose-response meta-analysis of thirty-one prospective studies. Br J Nutr. Nov 14 2021;126(9):1420–1430. doi:https://doi.org/10.1017/S0007114521000064

    Article  CAS  PubMed  Google Scholar 

  21. Steptoe A, Breeze E, Banks J, Nazroo J. Cohort profile: the English longitudinal study of ageing. Int J Epidemiol. Dec 2013;42(6):1640–8. doi:https://doi.org/10.1093/ije/dys168

    Article  PubMed  Google Scholar 

  22. Wang X, Jiang J, Hu Y, Qin LQ, Hao Y, Dong JY. Art Engagement and Risk of Type 2 Diabetes: Evidence From the English Longitudinal Study of Ageing. Int J Public Health. 2023;68:1605556. doi:https://doi.org/10.3389/ijph.2023.1605556

    Article  PubMed  PubMed Central  Google Scholar 

  23. Bhasin S, Travison TG, Manini TM, et al. Sarcopenia Definition: The Position Statements of the Sarcopenia Definition and Outcomes Consortium. J Am Geriatr Soc. Jul 2020;68(7):1410–1418. doi:https://doi.org/10.1111/jgs.16372

    Article  PubMed  Google Scholar 

  24. Valtorta NK, Kanaan M, Gilbody S, Hanratty B. Loneliness, social isolation and risk of cardiovascular disease in the English Longitudinal Study of Ageing. Eur J Prev Cardiol. Sep 2018;25(13):1387–1396. doi:https://doi.org/10.1177/2047487318792696

    Article  PubMed  Google Scholar 

  25. Clark BC, Manini TM. What is dynapenia? Nutrition. May 2012;28(5):495–503. doi:https://doi.org/10.1016/j.nut.2011.12.002

    Article  PubMed  PubMed Central  Google Scholar 

  26. Jun JE, Kang M, Jin SM, et al. Additive effect of low skeletal muscle mass and abdominal obesity on coronary artery calcification. Eur J Endocrinol. May 6 2021;184(6):867–877. doi:https://doi.org/10.1530/EJE-20-0885

    Article  CAS  PubMed  Google Scholar 

  27. Xia MF, Chen LY, Wu L, et al. Sarcopenia, sarcopenic overweight/obesity and risk of cardiovascular disease and cardiac arrhythmia: A cross-sectional study. Clin Nutr. Feb 2021;40(2):571–580. doi:https://doi.org/10.1016/j.clnu.2020.06.003

    Article  PubMed  Google Scholar 

  28. Fukuda T, Bouchi R, Takeuchi T, et al. Sarcopenic obesity assessed using dual energy X-ray absorptiometry (DXA) can predict cardiovascular disease in patients with type 2 diabetes: a retrospective observational study. Cardiovasc Diabetol. Apr 10 2018;17(1):55. doi:https://doi.org/10.1186/s12933-018-0700-5

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Evans K, Abdelhafiz D, Abdelhafiz AH. Sarcopenic obesity as a determinant of cardiovascular disease risk in older people: a systematic review. Postgrad Med. Nov 2021;133(8):831–842. doi:https://doi.org/10.1080/00325481.2021.1942934

    Article  PubMed  Google Scholar 

  30. Farmer RE, Mathur R, Schmidt AF, et al. Associations Between Measures of Sarcopenic Obesity and Risk of Cardiovascular Disease and Mortality: A Cohort Study and Mendelian Randomization Analysis Using the UK Biobank. J Am Heart Assoc. Jul 2 2019;8(13):e011638. doi:https://doi.org/10.1161/JAHA.118.011638

    Article  PubMed  PubMed Central  Google Scholar 

  31. Kim JH, Cho JJ, Park YS. Relationship between sarcopenic obesity and cardiovascular disease risk as estimated by the Framingham risk score. J Korean Med Sci. Mar 2015;30(3):264–71. doi:https://doi.org/10.3346/jkms.2015.30.3.264

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Gubelmann C, Vollenweider P, Marques-Vidal P. Association of grip strength with cardiovascular risk markers. Eur J Prev Cardiol. Mar 2017;24(5):514–521. doi:https://doi.org/10.1177/2047487316680695

    Article  PubMed  Google Scholar 

  33. Roh E, Choi KM. Health Consequences of Sarcopenic Obesity: A Narrative Review. Front Endocrinol (Lausanne). 2020;11:332. doi:https://doi.org/10.3389/fendo.2020.00332

    Article  PubMed  Google Scholar 

  34. RB VANH, Cushman M, Schlueter EF, Allison MA. Abdominal Muscle Density Is Inversely Related to Adiposity Inflammatory Mediators. Med Sci Sports Exerc. Jul 2018;50(7):1495–1501. doi:https://doi.org/10.1249/MSS.0000000000001570

    Article  Google Scholar 

  35. Schrager MA, Metter EJ, Simonsick E, et al. Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol (1985). Mar 2007;102(3):919–25. doi:https://doi.org/10.1152/japplphysiol.00627.2006

    Article  PubMed  Google Scholar 

  36. Bellanti F, Romano AD, Lo Buglio A, et al. Oxidative stress is increased in sarcopenia and associated with cardiovascular disease risk in sarcopenic obesity. Maturitas. Mar 2018;109:6–12. doi:https://doi.org/10.1016/j.maturitas.2017.12.002

    Article  CAS  PubMed  Google Scholar 

  37. Atkins JL, Whincup PH, Morris RW, Lennon LT, Papacosta O, Wannamethee SG. Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men. J Am Geriatr Soc. Feb 2014;62(2):253–60. doi:https://doi.org/10.1111/jgs.12652

    Article  PubMed  Google Scholar 

  38. Terauchi M, Odai T, Hirose A, Kato K, Akiyoshi M, Miyasaka N. Muscle and joint pains in middle-aged women are associated with insomnia and low grip strength: a cross-sectional study. J Psychosom Obstet Gynaecol. Mar 2020;41(1):15–21. doi:https://doi.org/10.1080/0167482X.2018.1530211

    Article  PubMed  Google Scholar 

  39. Shim J, Yoo HJ. Effects of Handgrip Strength on 10-Year Cardiovascular Risk among the Korean Middle-Aged Population: The Korea National Health and Nutrition Examination Survey 2014. Healthcare (Basel). Nov 4 2020;8(4)doi:https://doi.org/10.3390/healthcare8040458

    Google Scholar 

  40. Park J, Park H. Muscle strength and carotid artery flow velocity is associated with increased risk of atherosclerosis in adults. Cardiol J. 2017;24(4):385–392. doi:https://doi.org/10.5603/CJ.a2017.0007

    Article  PubMed  Google Scholar 

Download references

Acknowledgements: The authors would like to thank the UK data archive and ELSA research group for providing the data. The ELSA study was developed by University College London, the Institute of Fiscal Studies and the National Centre for Social Research. The developers and funders of ELSA had no roles in data analysis, interpretation and manuscript writing.

Funding

Funding: This work was supported by China Postdoctoral Science Foundation (grant no. 2023M730113 to X.Wang); National key research and development program of China (grant number 2022YFC3600804 to Y. Hao). The funders were not involved in the design, implementation, assessment, analysis or interpretation of the data; or the decision to submit the manuscript for publication.

Author information

Authors and Affiliations

Authors

Contributions

Authors’ contributions: Conceptualization: X. Wang and J-Y. Dong; Methodology: L-Q. Qin and Y. Hu; Formal Analysis: X. Wang and J-Y. Dong; Investigation: J.J and W. Hu; Writing - Original Draft Preparation: X. Wang; Writing - Review & Editing: J.J, W. Hu, L-Q. Qin, Y. Hu, Y. Hao, and J-Y. Dong. All authors saw and approved the final version and no other person made a substantial contribution to the paper.

Corresponding authors

Correspondence to Yuantao Hao or Jia-Yi Dong.

Ethics declarations

Ethics approval and consent to participate: ELSA has obtained ethical approval from the National Research Ethics Service (MREC/01/2/91). All the participants have completed informed consent before the surveys.

Competing interests: No potential conflicts of interest relevant to this article were reported.

Additional information

Consent for publication: Not applicable.

Electronic Supplementary Material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, X., Jiang, J., Hu, W. et al. Dynapenic Abdominal Obesity and Risk of Heart Disease among Middle-Aged and Older Adults: A Prospective Cohort Study. J Nutr Health Aging 27, 752–758 (2023). https://doi.org/10.1007/s12603-023-1975-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12603-023-1975-0

Key words

Navigation